Cargando…
Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
AIM: To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy. MATERIALS AND METHODS: This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684241/ https://www.ncbi.nlm.nih.gov/pubmed/29151685 http://dx.doi.org/10.5005/jp-journals-10028-1233 |
_version_ | 1783278433890992128 |
---|---|
author | S Khouri, Albert Huang, Grace Y Huang, Linda |
author_facet | S Khouri, Albert Huang, Grace Y Huang, Linda |
author_sort | S Khouri, Albert |
collection | PubMed |
description | AIM: To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy. MATERIALS AND METHODS: This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive trabeculectomies with MMC injection (injection group), and thirty eyes with sponge-applied MMC were as controls (sponge group). Data were collected preoperatively and postoperatively at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year after surgery. Demographic data, applanation intraocular pressure (IOP), best-corrected visual acuity (VA), number of glaucoma medications, postoperative interventions, postoperative complications, and number of visits within 3 months were recorded. In order to stratify data, proportion of eyes achieving >30% IOP reduction from baseline with or without glaucoma medications was calculated and defined as surgical success. RESULTS: Mean IOP reduction at 1 year was significant in both the injection and sponge groups from baseline (46.8 and 37.8% respectively). The injection group had overall lower postoperative IOP and comparable complete treatment success, defined as achieving >30% IOP reduction without glaucoma medications (p = 0.941). The number of postoperative visits within 3 months and the proportion of eyes needing 5-fluorouracil (5-FU) intervention were significantly lower in the injection group (p = 0.03, p = 0.04 respectively). CONCLUSION: Injection of MMC was as safe and effective as sponge application with comparable estimated complete treatment success, less need for visits within 3 months, and 5-FU intervention. CLINICAL SIGNIFICANCE: Surgeons may consider intraopera-tive injection of MMC in appropriate patient cohorts given comparable safety and efficacy and several advantages over traditional sponge application. Further study in a prospective, larger, long-term manner is necessary to assess this modality. How to cite this article: Khouri AS, Huang G, Huang LY. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study. J Curr Glaucoma Pract 2017;11(3):101-106. |
format | Online Article Text |
id | pubmed-5684241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-56842412017-11-17 Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study S Khouri, Albert Huang, Grace Y Huang, Linda J Curr Glaucoma Pract Original Article AIM: To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy. MATERIALS AND METHODS: This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive trabeculectomies with MMC injection (injection group), and thirty eyes with sponge-applied MMC were as controls (sponge group). Data were collected preoperatively and postoperatively at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year after surgery. Demographic data, applanation intraocular pressure (IOP), best-corrected visual acuity (VA), number of glaucoma medications, postoperative interventions, postoperative complications, and number of visits within 3 months were recorded. In order to stratify data, proportion of eyes achieving >30% IOP reduction from baseline with or without glaucoma medications was calculated and defined as surgical success. RESULTS: Mean IOP reduction at 1 year was significant in both the injection and sponge groups from baseline (46.8 and 37.8% respectively). The injection group had overall lower postoperative IOP and comparable complete treatment success, defined as achieving >30% IOP reduction without glaucoma medications (p = 0.941). The number of postoperative visits within 3 months and the proportion of eyes needing 5-fluorouracil (5-FU) intervention were significantly lower in the injection group (p = 0.03, p = 0.04 respectively). CONCLUSION: Injection of MMC was as safe and effective as sponge application with comparable estimated complete treatment success, less need for visits within 3 months, and 5-FU intervention. CLINICAL SIGNIFICANCE: Surgeons may consider intraopera-tive injection of MMC in appropriate patient cohorts given comparable safety and efficacy and several advantages over traditional sponge application. Further study in a prospective, larger, long-term manner is necessary to assess this modality. How to cite this article: Khouri AS, Huang G, Huang LY. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study. J Curr Glaucoma Pract 2017;11(3):101-106. Jaypee Brothers Medical Publishers 2017 2017-10-27 /pmc/articles/PMC5684241/ /pubmed/29151685 http://dx.doi.org/10.5005/jp-journals-10028-1233 Text en Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Original Article S Khouri, Albert Huang, Grace Y Huang, Linda Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study |
title | Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study |
title_full | Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study |
title_fullStr | Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study |
title_full_unstemmed | Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study |
title_short | Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study |
title_sort | intraoperative injection vs sponge-applied mitomycin c during trabeculectomy: one-year study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684241/ https://www.ncbi.nlm.nih.gov/pubmed/29151685 http://dx.doi.org/10.5005/jp-journals-10028-1233 |
work_keys_str_mv | AT skhourialbert intraoperativeinjectionvsspongeappliedmitomycincduringtrabeculectomyoneyearstudy AT huanggrace intraoperativeinjectionvsspongeappliedmitomycincduringtrabeculectomyoneyearstudy AT yhuanglinda intraoperativeinjectionvsspongeappliedmitomycincduringtrabeculectomyoneyearstudy |